Epizyme reported $523.52M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 209.42B 3.44B
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Amarin AMRN:US 2.01B 284.24M
Amgen AMGN:US $ 120.75B 19.29B
Avrobio Inc AVRO:US $ 243.58M 127.72M
Biogen BIIB:US $ 42.17B 9.96B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Cerulean Pharma CERU:US $ 117.77M 24.5M
Daiichi Sankyo 4568:JP 5801.19B 1139.01B
Eisai 4523:JP 2489.98B 750.02B
Epizyme EPZM:US $ 523.52M 323.9M
Exelixis EXEL:US $ 6.66B 950.22M
Gilead Sciences GILD:US $ 87.58B 1.22B
Glaxosmithkline GSK:US 95.15B 3.61B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Karyopharm Therapeutics KPTI:US $ 439.39M 335.56M
Macrogenics MGNX:US $ 1.28B 335.6M
Merk MRK:US $ 190131.55M 6786.63M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Novartis NVS:US 200.79B 24.12B
Novartis NOVN:VX 187.04B 20.99B
Pfizer PFE:US $ 241143.67M 21937.97M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Spectrum Pharmaceuticals SPPI:US $ 357.43M 257.97M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
Xencor XNCR:US $ 1.9B 103.31M